Convoy Expandable Corpectomy System
SeaSpine Orthopedics Corporation · Decision date Oct 29, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for the Convoy Expandable Corpectomy System, submitted by SeaSpine Orthopedics Corporation of Carlsbad, California, under 510(k) number K262574. The device falls under the classification name Spinal Vertebral Body Replacement Device, regulation number 888.3060, with classification product code MQP and subsequent product code PLR. The application was received 07/27/2026 and the decision date is 10/29/2026; the review panel and regulation medical specialty are both listed as Orthopedic.
SESE in a 510(k) context denotes clearance to market as substantially equivalent to a predicate device; it is not premarket approval. The record describes a Traditional 510(k), not reviewed by a third party, not a combination product, and without an authorized Predetermined Change Control Plan. The public record does not state which predicate device was used, what components or sizing the system includes, or any indications for use, so those details remain unknown here and would need the underlying FDA decision documents.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Orthopedic
- Decision date
- Oct 29, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K262574
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- SeaSpine Orthopedics Corporation
- Product code
- MQP
- Decision code
- SESE
- Decision date
- Oct 29, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Spinal Vertebral Body Replacement Device.
- Applicant
- SeaSpine Orthopedics Corporation
- Product code
- MQP
- FDA device class
- 2
FDA decision timeline
K262574 received
Application receipt date recorded by FDA.
K262574 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
SeaSpine Orthopedics Corporation
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Carlsbad, CA
Sources and methodology
- Original FDA record: K262574
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records